No fees award for PTAB proceedings, rules Fed Circuit

The US Court of Appeals for the Federal Circuit has said it cannot award attorneys’ fees for proceedings before the US Patent Trial and Appeal Board (PTAB).

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Ruling opens door for Noven’s oestrogen patch generics

10 September 2020 In a victory for pharmaceutical company Amneal, a Delaware court has invalidated claims of three patents covering Noven Pharmaceuticals’ Minivelle oestrogen product.

Americas

PTAB to review Minnesota patent after Gilead petition

2 June 2020 Gilead Sciences has persuaded the US Patent Trial and Appeal Board to review an antiviral patent owned by the University of Minnesota.

Americas

Cochlear's $268m damages bill stands, says Fed Circuit

20 May 2020 Australian ear implants manufacturer Cochlear must pay $268 million for infringing a patent owned by a US medical research organisation.

More on this story

Americas

Ruling opens door for Noven’s oestrogen patch generics

10 September 2020 In a victory for pharmaceutical company Amneal, a Delaware court has invalidated claims of three patents covering Noven Pharmaceuticals’ Minivelle oestrogen product.

Americas

PTAB to review Minnesota patent after Gilead petition

2 June 2020 Gilead Sciences has persuaded the US Patent Trial and Appeal Board to review an antiviral patent owned by the University of Minnesota.

Americas

Cochlear's $268m damages bill stands, says Fed Circuit

20 May 2020 Australian ear implants manufacturer Cochlear must pay $268 million for infringing a patent owned by a US medical research organisation.

More on this story

Americas

Ruling opens door for Noven’s oestrogen patch generics

10 September 2020 In a victory for pharmaceutical company Amneal, a Delaware court has invalidated claims of three patents covering Noven Pharmaceuticals’ Minivelle oestrogen product.

Americas

PTAB to review Minnesota patent after Gilead petition

2 June 2020 Gilead Sciences has persuaded the US Patent Trial and Appeal Board to review an antiviral patent owned by the University of Minnesota.

Americas

Cochlear's $268m damages bill stands, says Fed Circuit

20 May 2020 Australian ear implants manufacturer Cochlear must pay $268 million for infringing a patent owned by a US medical research organisation.